495 related articles for article (PubMed ID: 1314148)
21. 99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.
Blower PJ; Kettle AG; O'Doherty MJ; Coakley AJ; Knapp FF
Eur J Nucl Med; 2000 Sep; 27(9):1405-9. PubMed ID: 11007525
[TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid.
Lam AS; Puncher MR; Blower PJ
Eur J Nucl Med; 1996 Dec; 23(12):1575-82. PubMed ID: 8929310
[TBL] [Abstract][Full Text] [Related]
23. Incidental visualization of hepatic hemangioma during Tc-99m (v) DMSA, Tl-201, and Tc-99m MDP imaging.
Adalet I; Kocak M; Oguz H; Alagol F; Cantez S
Clin Nucl Med; 1995 Dec; 20(12):1106-7. PubMed ID: 8674308
[No Abstract] [Full Text] [Related]
24. [Local findings of renal cell carcinoma on 99m-Tc-DMSA renal, 99m-Tc-MDP bone and 67-Ga-citrate scintigraphies].
Kawamura J; Itoh H; Yoshida O; Fujita T; Fukunaga M; Morita R; Torizuka K
Kaku Igaku; 1982 Apr; 19(3):357-68. PubMed ID: 6290720
[No Abstract] [Full Text] [Related]
25. Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions.
Massardo T; Alonso O; Kabasakal L; Llamas-Olier A; Shankar UR; Zhu H; Delgado L; González P; Mut F; Padhy AK
J Nucl Med; 2002 Jul; 43(7):882-8. PubMed ID: 12097457
[TBL] [Abstract][Full Text] [Related]
26. Poor renal uptake of Tc-99m DMSA and Tc-99m MDP in a patient with Fanconi syndrome and near normal glomerular filtration rate.
Kim SE; Cho JT; Lee DS; Chung JK; Kim S; Lee MC; Lee JS; Koh CS
Clin Nucl Med; 1995 Mar; 20(3):215-9. PubMed ID: 7750213
[TBL] [Abstract][Full Text] [Related]
27. Images of liposarcoma using technetium-99m bleomycin and technetium (V)-99m DMSA.
Ohta H; Shane FI; Endo K; Torizuka K; Horiuchi K; Yokoyama A; Ishii M
Clin Nucl Med; 1986 Dec; 11(12):842-4. PubMed ID: 2434276
[TBL] [Abstract][Full Text] [Related]
28. The role of Tc-99m MDP and Ga-67 imaging in the clinical evaluation of malignant fibrous histiocytoma.
Lin WY; Kao CH; Hsu CY; Liao SQ; Wang SJ; Yeh SH
Clin Nucl Med; 1994 Nov; 19(11):996-1000. PubMed ID: 7842598
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic efficacy of technetium-99m pentavalent-dimercapto succinic acid versus gallium-67 citrate, imaging in patients with highly suspected acute bone and joint infections.
Koukouraki S; Gaitanis I; Hatjipaulou A; Karkavitsas N
Hell J Nucl Med; 2006; 9(2):99-102. PubMed ID: 16894413
[TBL] [Abstract][Full Text] [Related]
30. The detection of nasopharynx carcinoma in technetium-99m (V) dimercaptosuccinic acid SPECT imaging.
Kao CH; Wang SJ; Wey SP; Shen LH; Ting G; Yeh SH
Clin Nucl Med; 1993 Apr; 18(4):321-3. PubMed ID: 8386992
[TBL] [Abstract][Full Text] [Related]
31. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
[TBL] [Abstract][Full Text] [Related]
32. Technetium-99m-pentavalent dimercaptosuccinic acid uptake in Hurthle cell tumor of the thyroid.
Vergara E; Lastoria S; Varrella P; Lapenta L; Salvatore M
J Nucl Biol Med (1991); 1993 Jun; 37(2):65-8. PubMed ID: 8396979
[TBL] [Abstract][Full Text] [Related]
33. Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.
Papantoniou V; Tsiouris S; Mainta E; Valotassiou V; Souvatzoglou M; Sotiropoulou M; Nakopoulou L; Lazaris D; Louvrou A; Melissinou M; Tzannetaki A; Pirmettis I; Koutsikos J; Zerva C
Breast Cancer Res; 2005; 7(1):R33-45. PubMed ID: 15642168
[TBL] [Abstract][Full Text] [Related]
34. A comparison of the tumor-seeking agent Tc-99m(V) dimercaptosuccinic acid and the renal imaging agent Tc-99m dimercaptosuccinic acid in humans.
Ohta H; Ishii M; Yoshizumi M; Endo K; Sakahara H; Nakajima T; Yomoda I; Masuda H; Horiuchi K; Hata N
Clin Nucl Med; 1985 Mar; 10(3):167-70. PubMed ID: 2985320
[TBL] [Abstract][Full Text] [Related]
35. Scintigraphic evaluation of two cases with alveolar soft part sarcoma.
Ohta H; Ishii M; Endo K; Konishi J; Kotoura Y; Yamamuro T; Torizuka K
Ann Nucl Med; 1988 Nov; 2(2):89-93. PubMed ID: 2856319
[TBL] [Abstract][Full Text] [Related]
36. (99m)Tc(V)DMSA quantitatively predicts (188)Re(V)DMSA distribution in patients with prostate cancer metastatic to bone.
Blower PJ; Kettle AG; O'Doherty MJ; Coakley AJ; Knapp FF
Eur J Nucl Med; 2000 Sep; 27(9):1405-9. PubMed ID: 25084779
[TBL] [Abstract][Full Text] [Related]
37. Pentavalent technetium-99m DMSA uptake in pseudofractures of osteomalacia.
Sahin M; Basoglu T; Albayrak S; Canbaz F; Yapici O
Clin Nucl Med; 2001 Jan; 26(1):62-4. PubMed ID: 11139060
[TBL] [Abstract][Full Text] [Related]
38. Bone metastases demonstrated by pentavalent Tc-99m DMSA and Tc-99m HMDP.
Hirano T; Otake H
Clin Nucl Med; 1997 Sep; 22(9):640-1. PubMed ID: 9298304
[No Abstract] [Full Text] [Related]
39. Determination of medullary thyroid carcinoma metastases by 201Tl, 99Tcm(V)DMSA, 99Tcm-MIBI and 99Tcm-tetrofosmin.
Adalet I; Koçak M; Ogŭz H; Alagöl F; Cantez S
Nucl Med Commun; 1999 Apr; 20(4):353-9. PubMed ID: 10319355
[TBL] [Abstract][Full Text] [Related]
40. The visualization of pulmonary tuberculosis with Tc-99m (V) DMSA and Tc-99m citrate in comparison to Ga-67 citrate.
Gulaldi NC; Bayhan H; Ercan MT; Kibar M; Oztürk B; Oğretensoy M; Bekdik CF
Clin Nucl Med; 1995 Nov; 20(11):1012-4. PubMed ID: 8565355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
